At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
HVMN Ketone +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cross-over, Placebo-controlled, Randomized Trial of β-hydroxybutyrate in Prediabetes
In Brief
A clinical study evaluating HVMN Ketone and Placebo for PreDiabetes. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The study aims to investigate changes in blood glucose metabolism after administration of a ketone ester drink.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreDiabetes
CountriesNew Zealand
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedMar 2019
Enrollment StartApr 2019
Primary CompletionAug 2019
Study CompletionAug 2019
TodayJul 2026
First PostedMar 26, 2019
Enrollment StartApr 1, 2019
Primary CompletionAug 16, 2019
Study CompletionAug 30, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.3 years ago
Interventions
HVMN Ketoneother
Water-based, flavoured sport beverage
Placeboother
Water, stevia, malic acid, and thickening agent